Cargando…

Antiviral therapy of chronic HBV infection in pregnancy

We describe a 27-year-old hepatitis B virus (HBV)-infected pregnant woman, with a history of miscarriage a year ago. The patient has been HBsAg and HBeAg positive for 20 years but has never been treated for HBV infection, because of stable elevated alanine aminotransferase (ALT) activity and high vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikolajuk-Stasiuk, Julita, Czauz-Andrzejuk, Agnieszka, Łapiński, Tadeusz Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497434/ https://www.ncbi.nlm.nih.gov/pubmed/28856261 http://dx.doi.org/10.5114/ceh.2015.58041

Ejemplares similares

Effect of hepatitis B virus (HBV) infection on the course of pregnancy and newborns’ health status
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2015)

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy
por: Mazzaro, Cesare, et al.
Publicado: (2022)

Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection
por: Wang, Fuchuan, et al.
Publicado: (2022)

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)

An unusual renal manifestation of chronic HBV infection
por: Aravindan, Ananthakrishnapuram, et al.
Publicado: (2010)

Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus
por: Zhou, Jing, et al.
Publicado: (2021)

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†)
por: De Clercq, Erik, et al.
Publicado: (2010)

Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects
por: Vaillant, Andrew
Publicado: (2022)

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
por: Potestio, Luca, et al.
Publicado: (2023)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients With Chronic HBV Infection
por: Zhang, Hong, et al.
Publicado: (2020)

Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis
por: Wu, Yuchao, et al.
Publicado: (2020)

Resolved HBV behavior during the treatment of chronic HCV infection with direct-acting antivirals
por: Mohamed, Salem Y., et al.
Publicado: (2019)

Toxic hepatitis caused by the excretions of the Phyllomedusa bicolor frog – a case report
por: Pogorzelska, Joanna, et al.
Publicado: (2017)

Liver Transplantation during Pregnancy for Acute Liver Failure due to HBV Infection: A Case Report
por: Kimmich, Nina, et al.
Publicado: (2013)

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
por: Costantini, Andrea, et al.
Publicado: (2011)

Approximate solutions for HBV infection with stability analysis using LHAM during antiviral therapy
por: Aniji, M., et al.
Publicado: (2020)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Editorial: Interferon and its antiviral effect in response to HBV infection
por: Song, Hongxiao, et al.
Publicado: (2023)

Impact of rs12979860 polymorphism on liver morphology in chronic HCV infection
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2015)

Outcome of Combination Antiviral Therapy in Chronic Hepatitis C Virus Infection During Therapy of Acute Lymphoblastic Leukemia
por: Ayyub, Muhammad, et al.
Publicado: (2011)

An initial assessment of correlations between host- and virus-related factors affecting analogues antiviral therapy in HBV chronically infected patients
por: Stalke, Piotr, et al.
Publicado: (2014)

1248. Relationship Between ALT and New HBV Biomarkers in HBV/HIV Coinfected Persons Started on Antiviral Therapy
por: Rouster, Susan D, et al.
Publicado: (2022)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review
por: Du, Wenjun, et al.
Publicado: (2013)

Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection
por: Matsumoto, Kotaro, et al.
Publicado: (2018)

Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis
por: Li, Ping, et al.
Publicado: (2021)

An Unusual Cause for a Hepatic Flare in a Chronic HBV Carrier
por: Schulz, Marten, et al.
Publicado: (2014)

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
por: Downs, Louise O., et al.
Publicado: (2021)

Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment
por: Li, Xiaoyan, et al.
Publicado: (2017)

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020)

FibroScan Predicts Liver Fibrosis Progression in Chronic HBV Infection Patients with No Clear Indication for Antiviral Therapy: A Retrospective Cohort Study
por: Xu, Wei, et al.
Publicado: (2023)

Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy
por: Jiang, Bei, et al.
Publicado: (2022)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells
por: Gailhouste, Luc, et al.
Publicado: (2021)

Nutritional status in patients with liver cirrhosis
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2019)

Effect of FibroScan test in antiviral therapy for HBV-infected patients with ALT <2 upper limit of normal
por: Han, Xian-Zhi, et al.
Publicado: (2020)

High Serum Levels of TGF-β in Iranians With Chronic HBV Infection
por: Khorramdelazad, Hossein, et al.
Publicado: (2012)

Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
por: Zhong, Jiang-Li, et al.
Publicado: (2023)

Restoration of a functional antiviral immune response to chronic HBV infection by reducing viral antigen load: if not sufficient, is it necessary?
por: Yang, Sisi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bja7t0eum65ip0bb9cr6fet95u